Name: Neuroblastoma: Current State and Recent Updates (en Inglés)
SKU: 58995258
Price: 151.37 USD
Availability: InStock
Author: Gowda, Chandrika
ISBN: 9789535135838

portada Neuroblastoma: Current State and Recent Updates (en Inglés)

Neuroblastoma: Current State and Recent Updates (en Inglés)

Formato

Libro Físico

Editorial

Intechopen

Autor

Gowda, Chandrika

Idioma

Inglés

N° páginas

168

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1.1 cm

Peso

0.47 kg.

ISBN13

9789535135838

Categorías

Oncología

Neuroblastoma: Current State and Recent Updates (en Inglés)

Gowda, Chandrika (Autor) · Intechopen · Tapa Dura

Libro Nuevo Importado

Envío: 25 a 32 días háb.

$ 275.22$ 151.37

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 151.37

Llega entre el 20 Oct y el 04 Nov a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Neuroblastoma: Current State and Recent Updates (en Inglés)"

Neuroblastoma (NBL) is the most common extracranial solid tumor of childhood, with about 700 new cases of neuroblastoma seen each year in the United States. The 5-year survival rate for children with high-risk NBL is only 50-60%, and this survival rate has not improved over the last 10 years. High-risk patients receive multimodality treatment, including chemotherapy, surgery, radiation therapy, biologic therapy and immunotherapy, all of which are associated with significant morbidity. Recent years have seen many advances in treatment of neuroblastoma, including therapeutic MIBG, immunotherapy, and personalized targeted therapy based on the genetic alterations seen in the tumor. The primary objective of this book is to provide the readers with a comprehensive review of neuroblastoma, from clinical aspects and the currently available treatment to recent advancements and future directions in the field of NBL treatment. The topics and chapters have been compiled keeping in mind a diverse group of readers in different areas of specialty such as pediatric oncology, surgery, radiation oncology, and immunology, as well as physician scientists and basic researchers working in the field of neuroblastoma.